6505--Metoprolol Tartrate Tablets

The Department of Veterans Affairs National Acquisition Center is soliciting offers for Metoprolol Tartrate Tablets (Solicitation No. 36E79725R0071) through an unrestricted competitive procurement. The solicitation seeks pharmaceutical products in multiple package sizes and strengths to support the VA, Department of Defense, Indian Health Service, and Bureau of Prisons. Key requirements include submission of pricing for a base year plus four one-year option periods, provision of a unique 11-digit NDC number, compliance with FDA manufacturing and packaging requirements, and inclusion of a 0.5% Cost Recovery Fee in all pricing. One aggregate award will be made for all line items, and offerors must submit pricing for all line items to be considered for award. The amended offer due date is November 21, 2025 at 2:30 PM Central Standard Time.

This solicitation carries a small business set-aside designation with a size standard of 1,300 employees, though no specific incumbent contractor is identified in the solicitation documents. Estimated annual usage ranges from 2,715 to 174,928 bottles across different strengths and package sizes (100, 500, and 1,000 tablets per bottle), providing insight into the contract's scale and scope. The contract structure includes a base year followed by four one-year option periods, allowing for potential long-term engagement with the selected vendor. While specific award values or budget ranges are not disclosed in the solicitation notice, the volume of estimated annual usage suggests a substantial pharmaceutical procurement. Performance will be executed at the respective distribution and dispensing facilities of the VA, DoD, IHS, and Bureau of Prisons locations.